HCA Healthcare (HCA)
NYSEHealth CareMedical Care FacilitiesSnapshot 2026-07-07
$423.10+1.45%
Close 2026-07-07 · 1-day change
Reading HCA? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track HCA free→NYSEHealth CareMedical Care FacilitiesSnapshot 2026-07-07
Reading HCA? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track HCA free→QuarterlyIQ Insights · HCA
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Executive Vice President and Chief Clinical Officer — Dr. Michael Cuffe: Dr. Cuffe is stepping down as Executive Vice President and Chief Clinical Officer.
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information provided in
Entry into a Material Definitive Agreement. Issuance of $3,000,000,000 aggregate principal amount of senior notes Overview On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due 2031 (the “2031 Notes”), (ii) $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2033 (the “2033 Notes”) and (iii) $…
Other Events On April 27, 2026, HCA Healthcare, Inc. (the “Registrant”) issued a press release (the “Press Release”) announcing the commencement of its proposed public offering by HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of the Registrant, of senior unsecured notes (the “Offering”). The text of the Press Release is set forth as Exhibit 99.1 and is incorporated herein by reference. On April 27, 2026, the Issuer provided notice of its election to redeem all $1.500 billion of i…
Other Events. On April 24, 2026, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.78 per share of the Company’s common stock. The dividend will be paid on June 30, 2026 to stockholders of record at the close of business on June 16, 2026.
Results of Operations and Financial Condition. On April 24, 2026, HCA Healthcare, Inc. (the “Company”) issued a press release announcing, among other matters, its results of operations for the first quarter ended March 31, 2026, the text of which is set forth as Exhibit 99.1 .
The filing describes a new performance-based compensation program for executive officers.
Results of Operations and Financial Condition. On January 27, 2026, HCA Healthcare, Inc. (the “Company”) issued a press release announcing, among other matters, its results of operations for the fourth quarter and year ended December 31, 2025, the text of which is set forth as Exhibit 99.1 .
Other Events. On January 27, 2026, the Company announced that its Board of Directors had authorized an additional share repurchase program for up to $10 billion of the Company’s outstanding common stock. Repurchases will be made in accordance with applicable securities laws from time to time in the open market, through privately negotiated transactions, or otherwise. On January 27, 2026, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.78 per shar…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information provided in
Entry into a Material Definitive Agreement. Issuance of $3,250,000,000 aggregate principal amount of senior notes Overview On October 31, 2025, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $500,000,000 aggregate principal amount of its 4.300% Senior Notes due 2030 (the “2030 Notes”), (ii) $1,000,000,000 aggregate principal amount of its 4.600% Senior Notes due 2032 (the “2032 Notes”), (iii) $1…
Other Events On October 27, 2025, HCA Healthcare, Inc. (the “Registrant”) issued a press release (the “Press Release”) announcing the commencement of its proposed public offering by HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of the Registrant, of senior unsecured notes (the “Offering”). The text of the Press Release is set forth as Exhibit 99.1 and is incorporated herein by reference. On October 27, 2025, the Issuer provided notice of its election to redeem all $1.500 billion…
Other Events. On October 24, 2025, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.72 per share of the Company’s common stock. The dividend will be paid on December 29, 2025 to stockholders of record at the close of business on December 15, 2025.
Results of Operations and Financial Condition. On October 24, 2025, HCA Healthcare, Inc. (the “Company”) issued a press release announcing, among other matters, its results of operations for the third quarter ended September 30, 2025, the text of which is set forth as Exhibit 99.1 .
Results of Operations and Financial Condition. On July 25, 2025, HCA Healthcare, Inc. (the “Company”) issued a press release announcing, among other matters, its results of operations for the second quarter ended June 30, 2025, the text of which is set forth as Exhibit 99.1 .
Other Events. On July 25, 2025, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.72 per share of the Company’s common stock. The dividend will be paid on September 30, 2025 to stockholders of record at the close of business on September 16, 2025.
Director — John W. Chidsey, III: Appointment of a new director to the Board.
Creation of a Direct Financial Obligation or an Obligation or an Off-Balance Sheet Arrangement of a Registrant. The information set forth under
Other Events On June 10, 2025, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), established a commercial paper program under which the Issuer may issue unsecured commercial paper notes (the “Notes”) from time to time up to a maximum aggregate face or principal amount of $4.0 billion outstanding at any time, unconditionally guaranteed by the Parent Guarantor. Amounts available under the program may be borrowed, repaid and reborrowed f…
The filing details the compensation program for non-management directors and an amendment to a stock incentive plan, which are routine corporate governance matters.
Other Events. On April 25, 2025, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.72 per share of the Company’s common stock. The dividend will be paid on June 30, 2025 to stockholders of record at the close of business on June 16, 2025.
Results of Operations and Financial Condition. On April 25, 2025, HCA Healthcare, Inc. (the “Company”) issued a press release announcing, among other matters, its results of operations for the first quarter ended March 31, 2025, the text of which is set forth as Exhibit 99.1 .
The filing describes a new performance-based compensation program for executive officers.
Entry into a Material Definitive Agreement. Issuance of $5,250,000,000 aggregate principal amount of senior notes Overview On February 21, 2025, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $700,000,000 aggregate principal amount of its 5.000% Senior Notes due 2028 (the “ 2028 Notes”), (ii) $300,000,000 aggregate principal amount of its Floating Rate Senior Notes due 2028 (the “Floating Rate N…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information provided in
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.